Stone House Investment Management’s AbbVie ABBV Stock Holding History

Stone House Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$135K	Buy	535 +5	+0.9%	+$1.08K	0.02%	121
2026 Q1	$115K	Buy	530 +39	+8%	+$8.65K	0.02%	109
2025 Q4	$112K	Buy	491 +3	+0.6%	+$683	0.02%	112
2025 Q3	$113K	Buy	488 +5	+1%	+$1.02K	0.02%	108
2025 Q2	$89.7K	Buy	483 +220	+84%	+$40.9K	0.02%	113
2025 Q1	$55.2K	Buy	+263	New	+$51.1K	0.01%	138
2024 Q4	–	Sell	-277	Closed	-$54.8K	–	52
2024 Q3	$54.8K	Hold	277	–	–	0.01%	112
2024 Q2	$47.6K	Hold	277	–	–	0.01%	127
2024 Q1	$50.5K	Buy	277 +191	+222%	+$32.9K	0.01%	131
2023 Q4	$13.3K	Buy	86 +1	+1%	+$146	﹤0.01%	146
2023 Q3	$12.7K	Hold	85	–	–	﹤0.01%	148
2023 Q2	$11.4K	Sell	85 -149	-64%	-$21.9K	﹤0.01%	151
2023 Q1	$37.3K	Buy	+234	New	+$35.8K	0.01%	99
2019 Q2	–	Sell	-35	Closed	-$3K	–	38
2019 Q1	$3K	Buy	+35	New	+$2.86K	﹤0.01%	196

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Stone House Investment Management's ABBV Position: Q2 2026 in Review

Stone House Investment Management increased its AbbVie (ABBV) stake by 0.94% in Q2 2026, buying an estimated $1.08K and bringing the position to 535 shares worth $135K. The position accounts for 0.02% of the portfolio, ranked #121.

Stone House Investment Management first reported a position in ABBV in Q1 2019 and has held it in 14 quarters since. 4,238 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Stone House Investment Management held 535 shares of AbbVie worth $135K as of Q2 2026.
Stone House Investment Management bought 5 AbbVie shares in Q2 2026, an estimated $1.08K.
AbbVie made up 0.02% of Stone House Investment Management's portfolio in Q2 2026, its #121 holding.
Stone House Investment Management first reported a position in AbbVie in Q1 2019 and has held it in 14 quarters since.
4,238 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Stone House Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.